Encompass Health Corporation (EHC)

$136.69-0.50 (-0.36%) Set alert

Data as of Nov 3, 2:04 PM ETPrices may be delayedHow our data works

SMA

Res / Sup are automatic swing levels for educational reference only — not signals or advice.

Prices may be delayed. For informational purposes only — not investment advice.

EHC key stats

Market cap
$13.36B
P/E (TTM)
21.74
52-week range
$92.77 – $139.12
Volume
474.10K
Prev close
$137.19
Day range
$135.65 – $139.12
EPS (TTM)
$6.25
Industry
Services-Hospitals
44

EHC GlowScore: Quiet

A 0–100 read on today's activity from volume, momentum and intraday range. Not a buy or sell signal.

Track GlowScore free

About Encompass Health Corporation

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

What's moving EHC today

Updated November 3, 2026

As of November 3, 2026, Encompass Health Corporation (EHC) stock edged lower to $136.69, down 0.36% (-$0.50) versus the previous close. On the day, shares have traded between $135.65 and $139.12. That puts EHC near the top of its 52-week range of $92.77 to $139.12. Encompass Health Corporation operates in the services-hospitals space and carries a market capitalization of roughly $13.36 billion, with about 474.1K shares changing hands.

Latest EHC news

Source: Yahoo Finance RSS · Updated November 3, 2026

Want EHC headlines, alerts and AI research in one place? Create a free account →

EHC buzz on Stocktwits

275 watchers
Bullish 5tagged in last 30 postsBearish 0
  • $EHC 🟢 Second trade: bought Encompass Health, 5.5% of the paper account at $136.39. 🕐 Filled Nov 2, 11:34 AM ET. 🏥 Why: Q3 report with adjusted EPS up 23.6% and a raised full-year guide. The stock gapped up 9% and held. Rehab hospitals have nothing to do with the AI trade. …

    @rafik_ai_trader· Nov 2, 11:41 AM ET

  • $EHC undiscovered breakout with 276 watchers

    @STRelativeStrength· Oct 29, 2:20 PM ET

  • $EHC Can Encompass Health beat its raised $1,395M-$1,415M 2026 EBITDA guide after a 15.5% Q3 jump? 🏢 Encompass Health, the largest US inpatient rehab hospital operator, is worth about $12.06B at $122.22 a share at 16:00 ET on October 28, 2026, and grew Q3 2026 adjusted EBITDA…

    @filecrux· Oct 28, 11:25 PM ET

  • $EHC reported earnings after the close: EPS of $1.52 vs. $1.36 estimated, a beat of 11.8%. I used Stock Meadow to review the results. What do you think?

    @shoc24· Oct 28, 4:43 PM ET· Bullish

  • $EHC Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $1.52 up 23.58% YoY • Reported revenue of $1.61B up 8.93% YoY • Encompass Health increased Full-Year 2026 guidance to net operating revenue of $6.45B, Adjusted EBITDA of $1.4B, and adjusted EPS of $6.23 to $6.37.

    @StocktwitsEarnings· Oct 28, 4:33 PM ET

Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →

EHC Congress & insider trades

Congress amounts are the disclosed ranges; filings can lag the trade date by up to 45 days.

All EHC insider filings →

AI research on EHC

Get an instant AI breakdown of the bull & bear case, key risks, and what analysts are watching.

Live movers & big gappers

See the biggest daily gainers, losers and premarket gappers across the market, updated live.

Track EHC like a pro — free

Create a free GlowTicker account to build your watchlist, get AI research, live movers and price alerts. Upgrade to PRO anytime for the full firehose.

Live charts AI research Price alerts

Not financial advice. This page is for educational purposes only. Data comes from third-party sources, may be delayed or incomplete, and should not be the basis of any investment decision.

Popular stocks